These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8473426)

  • 1. A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization.
    MacDougall MJ; Tan SL; Balen A; Jacobs HS
    Hum Reprod; 1993 Feb; 8(2):233-7. PubMed ID: 8473426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro fertilization and the ovarian hyperstimulation syndrome.
    MacDougall MJ; Tan SL; Jacobs HS
    Hum Reprod; 1992 May; 7(5):597-600. PubMed ID: 1639974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triggering ovulation with gonadotropin-releasing hormone agonist in in vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol levels.
    Manzanares MA; Gómez-Palomares JL; Ricciarelli E; Hernández ER
    Fertil Steril; 2010 Mar; 93(4):1215-9. PubMed ID: 19200978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of the clinical outcomes of IVF-ET treatment in infertile patients with polycystic ovary syndrome or polycystic ovaries].
    Wang QL; Song J; Chen SL; Luo C; Chen X; Li M; Ni YP
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 May; 29(5):962-5. PubMed ID: 19460721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follicular aspiration during the selection phase prevents severe ovarian hyperstimulation in patients with polycystic ovary syndrome who are undergoing in vitro fertilization.
    Zhu WJ; Li XM; Chen XM; Zhang L
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):79-84. PubMed ID: 16154042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.
    Damario MA; Barmat L; Liu HC; Davis OK; Rosenwaks Z
    Hum Reprod; 1997 Nov; 12(11):2359-65. PubMed ID: 9436663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of intracytoplasmic sperm injection in patients with polycystic ovary syndrome or isolated polycystic ovaries.
    Esinler I; Bayar U; Bozdag G; Yarali H
    Fertil Steril; 2005 Oct; 84(4):932-7. PubMed ID: 16213846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer].
    Yu R; Lin J; Zhao JZ; Wang PY; Xiao SQ; Zhang W
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):250-4. PubMed ID: 22781109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy and neonatal outcomes following luteal GnRH antagonist administration in patients with severe early OHSS.
    Lainas GT; Kolibianakis EM; Sfontouris IA; Zorzovilis IZ; Petsas GK; Lainas TG; Tarlatzis BC
    Hum Reprod; 2013 Jul; 28(7):1929-42. PubMed ID: 23624582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro maturation versus IVF with GnRH antagonist for women with polycystic ovary syndrome: treatment outcome and rates of ovarian hyperstimulation syndrome.
    Das M; Son WY; Buckett W; Tulandi T; Holzer H
    Reprod Biomed Online; 2014 Nov; 29(5):545-51. PubMed ID: 25262236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro maturation of oocytes from unstimulated polycystic ovaries.
    Tan SL; Child TJ
    Reprod Biomed Online; 2002; 4 Suppl 1():18-23. PubMed ID: 12470331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assisted conception using buserelin and human menopausal gonadotrophins in women with polycystic ovary syndrome.
    Wada I; Matson PL; Troup SA; Lieberman BA
    Br J Obstet Gynaecol; 1993 Apr; 100(4):365-9. PubMed ID: 8494838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes.
    Walls ML; Hunter T; Ryan JP; Keelan JA; Nathan E; Hart RJ
    Hum Reprod; 2015 Jan; 30(1):88-96. PubMed ID: 25355587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study on the outcomes of in vitro fertilization between women with polycystic ovary syndrome and those with sonographic polycystic ovary-only in GnRH antagonist cycles.
    Kim YJ; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM; Kim JG; Moon SY
    Arch Gynecol Obstet; 2010 Aug; 282(2):199-205. PubMed ID: 20182736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.
    Babayof R; Margalioth EJ; Huleihel M; Amash A; Zylber-Haran E; Gal M; Brooks B; Mimoni T; Eldar-Geva T
    Hum Reprod; 2006 May; 21(5):1260-5. PubMed ID: 16439507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum albumin levels in women with ovarian hyperstimulation syndrome with or without polycystic ovaries.
    Alserri A; Holzer H; Tulandi T
    J Obstet Gynaecol Can; 2012 Sep; 34(9):866-869. PubMed ID: 22971456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Outcome of follicular aspiration of selection phase in patients with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation].
    Zhu WJ; Li XM; Chen XM; Zhang L
    Zhonghua Fu Chan Ke Za Zhi; 2004 Aug; 39(8):522-5. PubMed ID: 15363349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of dyslipidemia on IVF/ICSI pregnancy outcome in patients with polycystic ovary syndrome].
    Li X; Ding W; Liu JY; Mao YD; Huang J; Wang W; Ma X
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):402-408. PubMed ID: 29961283
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study.
    Engmann L; DiLuigi A; Schmidt D; Nulsen J; Maier D; Benadiva C
    Fertil Steril; 2008 Jan; 89(1):84-91. PubMed ID: 17462639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.